Canada markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9300-0.0100 (-0.34%)
At close: 04:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts2222
Avg. Estimate-1.14-0.76-2.5-3.01
Low Estimate-1.57-0.82-2.88-3.25
High Estimate-0.7-0.69-2.11-2.76
Year Ago EPS-80.4-13.25-2.5
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts3132
Avg. Estimate320k250k1.51M2.26M
Low Estimate200k250k1.4M1.93M
High Estimate500k250k1.7M2.6M
Year Ago Sales1.12M297k5.63M1.51M
Sales Growth (year/est)-71.50%-15.80%-73.20%49.70%
Earnings History2022-12-302023-03-302023-06-292023-09-29
EPS Est.-1.88-1.84-1.3-1.01
EPS Actual-80.4-1.07-0.81
Difference-6.122.240.230.2
Surprise %-325.50%121.70%17.70%19.80%
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate-1.14-0.76-2.5-3.01
7 Days Ago-1.14-0.76-2.5-3.01
30 Days Ago-1.14-0.76-2.5-3.01
60 Days Ago-1.14-0.76-2.5-3.01
90 Days Ago-1.14-0.76-2.5-3.01
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesOCXIndustrySector(s)S&P 500
Current Qtr.85.80%N/AN/AN/A
Next Qtr.-290.00%N/AN/AN/A
Current Year81.10%N/AN/AN/A
Next Year-20.40%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A